MyBlueDots

Half of people stop taking popular weight-loss drug within a year, study finds

The new class of anti-obesity drugs, glucagon-like peptide-1 receptor agonists (GLP-1RAs), is proving remarkably effective at helping individuals lose weight. However, a new population-wide study presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD), Vienna (15–19 Sept) finds that half of adults without diabetes who start taking the weight-loss drug semaglutide in Denmark discontinue treatment within a year.
Read More

Study shows smoking increases the risk of type 2 diabetes, regardless of its characteristics

The characteristics of type 2 diabetes vary from patient to patient and it has been proposed that the condition is made up of four subtypes. Now, new research presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria (15–19 September) shows that smoking increases the risk of the condition, regardless of subtype.
Read More

Links between diabetes and depression are similar across Europe, study of over-50s in 18 countries finds

The relative increase in odds of an individual with diabetes developing severe symptoms of depression—and vice versa—is the same, regardless of where they live, a study of over-50s in 18 countries in Europe presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria (15–19 September) has found.
Read More
Top